SCHEMBL17034989

SCHEMBL17034989

c1ccc(-c2nc3ccccc3c3c2cc(-c2c4ccccc4c(-c4ccc5ccccc5n4)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
PDE10A Q9Y233 2/20 0.39
AR P10275 6/20 0.37
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
CYP3A4 P08684 2/20 0.37
ADORA2A P29274 1/20 0.37
NUDT1 P36639 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035087 0.89 NPC1 (0.39) NPC1RAB9APDE10AARKDM4E
SCHEMBL17034964 0.83 MEN1 (0.42) PDE10AKDM4EALDH1A1MAPTHPGD
SCHEMBL17035044 0.81 ESR1 (0.39) NPC1RAB9APDE10AARKDM4E
SCHEMBL17035011 0.81 MEN1 (0.42) NPC1RAB9APDE10AARKDM4E
SCHEMBL17035124 0.81 NUDT1 (0.41) PDE10AKDM4EALDH1A1MAPTHPGD
SCHEMBL17034985 0.81 ALDH1A1 (0.42) NPC1RAB9APDE10AARKDM4E
SCHEMBL17034983 0.80 MEN1 (0.48) KDM4EALDH1A1MAPTHPGDADORA2A
SCHEMBL18200917 0.79 ESR1 (0.40) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL20967927 0.78 TOP1 (0.44) NPC1RAB9APDE10AARKDM4E
SCHEMBL13706309 0.78 NPC1 (0.49) NPC1RAB9APDE10AARKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 NPC1 1654/4885RAB9A 2456/4885PDE10A 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.